Helge Lubenow

Helge Lubenow

Chairman at EPIGENOMICS AG

56 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Helge Lubenow is a Chairman-Supervisory Board at Epigenomics AG.
She is on the Board of Directors at Biofrontera AG, Avelo AG, Indical Bioscience GmbH, Evorion Biotechnologies GmbH, HUMAN Gesellschaft für Biochemica und Diagnostica mbH, Indical Topco AB and NeraCare GmbH.
Dr. Lubenow was previously employed as a Managing Director by Proteomedix AG, a Managing Director by tesa Labtec GmbH, a Founder by Agos Consulting, and a Senior Vice President by QIAGEN GmbH.
She received her undergraduate degree from the University of Giessen and a doctorate degree from Universität zu Köln.

Helge Lubenow active positions

CompaniesPositionStart
EPIGENOMICS AG Chairman 2023-01-31
BIOFRONTERA AG Director/Board Member 2021-12-13
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Evorion Biotechnologies GmbH Director/Board Member -
Director/Board Member -
All active positions of Helge Lubenow

Former positions of Helge Lubenow

CompaniesPositionEnd
Chief Executive Officer 2019-12-30
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░ ░░░░░░░░░░ ░░░░░░░ -
See the detail of Helge Lubenow's experience

Training of Helge Lubenow

Universität zu Köln Doctorate Degree
University of Giessen Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helge Lubenow's experience

Connections

45

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
EPIGENOMICS AG

Health Technology

BIOFRONTERA AG

Health Technology

Private companies10

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Agos Consulting

Health Services

Finance

Health Services

Evorion Biotechnologies GmbH

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW